Objectives: Inhibition of estradiol production by letrozole may interfere with physiological effects of progesterone necessary to maintain the pregnancy. Treatment of tubal pregnancy (TP) with letrozole would allow to avoid the disadvantages of methotrexate (MTX). The aim was to compare the effectiveness of letrozole with MTX in the management of TP.
Material and methods: A prospective open-label cohort study was conducted among women with TP and increasing B-human chorionic gonadotropin (B-hCG) concentrations. MTX was administered in a single dose of 100 mg intravenously, while letrozole in a dose of 5 mg orally for 10 days. Blood parameters (B-hCG, hemoglobin, creatinine, urea, transaminases, bilirubin) were tested on days 0, 4 and 7.
Results: Out of 22 eligible women, 14 received MTX and received 8 letrozole. Mean age, lesion diameter, gestation age in the MTX vs letrozole arm were: 31 vs 32 years (p = 0.3), 13.2 vs 16.3 mm (p = 0.1), 7 + 1 vs 7 + 0 weeks (p = 0.6), respectively. In case of 4 women treated with letrozole and in 2 treated with MTX (4/8, 50% vs 2/14, 14.3%, p = 0.07) the treatment was unsuccessful. There were no significant differences in blood parameters on days 0, 4 and 7 between both arms, except for the increasing urea concentration in the letrozole arm (p = 0.01).
Conclusions: Even though the results did not reach statistical significance, it is likely that a larger study sample would confirm the trend of letrozole being less effective. The results did not support the use of letrozole in the studied regimen as an alternative to MTX.
目的:来曲唑抑制雌二醇的产生可能会干扰孕酮维持妊娠所需的生理效应。来曲唑治疗输卵管妊娠(TP)可避免甲氨蝶呤(MTX)的缺点。研究旨在比较来曲唑与MTX在治疗输卵管妊娠中的有效性:在患有TP且B-人绒毛膜促性腺激素(B-hCG)浓度升高的女性中开展了一项前瞻性开放标签队列研究。MTX单剂量静脉注射100毫克,来曲唑5毫克口服,共10天。第 0、4 和 7 天检测血液参数(B-hCG、血红蛋白、肌酐、尿素、转氨酶、胆红素):在 22 名符合条件的妇女中,14 人接受了 MTX 治疗,8 人接受了来曲唑治疗。MTX治疗组和来曲唑治疗组的平均年龄、病变直径和妊娠年龄分别为31岁和32岁(P = 0.5):分别为:31 岁 vs 32 岁(P = 0.3)、13.2 mm vs 16.3 mm(P = 0.1)、7 + 1 vs 7 + 0 周(P = 0.6)。4名妇女接受来曲唑治疗,2名妇女接受MTX治疗(4/8,50% vs 2/14,14.3%,p = 0.07),治疗均未成功。除了来曲唑治疗组尿素浓度升高(p = 0.01)外,两组患者在第 0、4 和 7 天的血液参数无明显差异:尽管结果没有达到统计学意义,但更大的研究样本可能会证实来曲唑效果较差的趋势。研究结果不支持在研究方案中使用来曲唑替代MTX。
{"title":"Off-label letrozole for tubal pregnancy monotherapy is not an alternative to methotrexate: a prospective cohort study.","authors":"Iwona M Gawron, Dorota Babczyk, Robert Jach","doi":"10.5603/gpl.100131","DOIUrl":"https://doi.org/10.5603/gpl.100131","url":null,"abstract":"<p><strong>Objectives: </strong>Inhibition of estradiol production by letrozole may interfere with physiological effects of progesterone necessary to maintain the pregnancy. Treatment of tubal pregnancy (TP) with letrozole would allow to avoid the disadvantages of methotrexate (MTX). The aim was to compare the effectiveness of letrozole with MTX in the management of TP.</p><p><strong>Material and methods: </strong>A prospective open-label cohort study was conducted among women with TP and increasing B-human chorionic gonadotropin (B-hCG) concentrations. MTX was administered in a single dose of 100 mg intravenously, while letrozole in a dose of 5 mg orally for 10 days. Blood parameters (B-hCG, hemoglobin, creatinine, urea, transaminases, bilirubin) were tested on days 0, 4 and 7.</p><p><strong>Results: </strong>Out of 22 eligible women, 14 received MTX and received 8 letrozole. Mean age, lesion diameter, gestation age in the MTX vs letrozole arm were: 31 vs 32 years (p = 0.3), 13.2 vs 16.3 mm (p = 0.1), 7 + 1 vs 7 + 0 weeks (p = 0.6), respectively. In case of 4 women treated with letrozole and in 2 treated with MTX (4/8, 50% vs 2/14, 14.3%, p = 0.07) the treatment was unsuccessful. There were no significant differences in blood parameters on days 0, 4 and 7 between both arms, except for the increasing urea concentration in the letrozole arm (p = 0.01).</p><p><strong>Conclusions: </strong>Even though the results did not reach statistical significance, it is likely that a larger study sample would confirm the trend of letrozole being less effective. The results did not support the use of letrozole in the studied regimen as an alternative to MTX.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: The aim of this study was to investigate the prevalence of Group B Streptococcus (GBS) colonization in pregnancies between 35 and 37 weeks of gestation and to compare the effectiveness of polymerase chain reaction (PCR) method with gold standard technique of culture in antenatal GBS screening.
Material and methods: Vaginal and rectal swabs of a total of 106 pregnant women between 35th and 37th weeks of gestation, who were admitted to our clinic between January 2022 and August 2022, were evaluated using culture and PCR method. The prevalence of GBS was estimated. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of the PCR method were analyzed.
Results: The prevalence of GBS was 10.4% and 21.69% using the culture and PCR method, respectively. Compared to the culture, the sensitivity, specificity, PPV, NPV and accuracy of PCR were found to be 100%, 87%, 47%, 100%, and 88%, respectively.
Conclusions: This study results suggest that the PCR method is a simple, effective and fast method with high sensitivity, specificity, PPV, and NPV in antenatal GBS screening.
{"title":"Comparison of Polymerase Chain Reaction Method with Culture Method in Antenatal Group B Streptococcus Screening.","authors":"Doğukan Çopur, Özlem Koyuncu Özyurt, Hülya Kandemir, Betil Özhak, Dilara Öğünç, İnanc Mendilcioğlu Mendilcioğlu","doi":"10.5603/gpl.99055","DOIUrl":"https://doi.org/10.5603/gpl.99055","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to investigate the prevalence of Group B Streptococcus (GBS) colonization in pregnancies between 35 and 37 weeks of gestation and to compare the effectiveness of polymerase chain reaction (PCR) method with gold standard technique of culture in antenatal GBS screening.</p><p><strong>Material and methods: </strong>Vaginal and rectal swabs of a total of 106 pregnant women between 35th and 37th weeks of gestation, who were admitted to our clinic between January 2022 and August 2022, were evaluated using culture and PCR method. The prevalence of GBS was estimated. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of the PCR method were analyzed.</p><p><strong>Results: </strong>The prevalence of GBS was 10.4% and 21.69% using the culture and PCR method, respectively. Compared to the culture, the sensitivity, specificity, PPV, NPV and accuracy of PCR were found to be 100%, 87%, 47%, 100%, and 88%, respectively.</p><p><strong>Conclusions: </strong>This study results suggest that the PCR method is a simple, effective and fast method with high sensitivity, specificity, PPV, and NPV in antenatal GBS screening.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrycja Glinska, Anna Macios, Rafal Jaworski, Marcin Bobinski, Dominik Pruski, Marcin Przybylski, Aleksandra Zielinska, Wlodzimierz Sawicki, Andrzej Nowakowski
Objectives: Free-of-charge vaccination against human papillomavirus (HPV-) of 12-13-year-old teenagers was introduced on the 1st of June 2023 in Poland. Data on baseline HPV- genotype cervical distribution are crucial to evaluate potential changes after full implementation of the vaccination program. We aimed at evaluating the status of HPV- infection and distribution of HPV- genotypes in cervical cytology of gynecological patients tested in one of the largest HPV- laboratories in Poland.
Material and methods: Data on all HPV- tests performed in ALAB Laboratoria Sp. z o. o. in Poland in 2018-2021 were analyzed, focusing on tests that identified genotypes: 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 62, 66, 67, 68, 70, 73, 81, 82, 83, 89. Distribution of HPV- genotypes was assessed among HPV--positive women.
Results: Among 11.151 medical records retrieved in women with valid HPV- test results, 5.681 were positive (50.9%), of whom 2.929 were infected with a single genotype (51.6%). At least one high-risk (HR) genotype was detected in 4.351 women (76.6%). Among all HPV--positive women, the most common HR genotypes were HPV--16, HPV--31 and HPV--66 (24.0%, 11.3%, 11.3%, respectively). HPV--53 was the most prevalent among non-HR types (10.5%).
Conclusions: HPV--16 followed by HPV--31 and HPV--66 were the most frequent genotypes in the studied cohort. These results may be compared with the same methodology after full roll-out of HPV- vaccination program in the future to track potential changes in HPV- genotype distribution.
{"title":"Baseline data on distribution of human papillomavirus (HPV-) genotypes in cervical samples of gynecological patients before implementation of population-based HPV- vaccination program in Polande implementation of population-based HPV vaccination program in Poland.","authors":"Patrycja Glinska, Anna Macios, Rafal Jaworski, Marcin Bobinski, Dominik Pruski, Marcin Przybylski, Aleksandra Zielinska, Wlodzimierz Sawicki, Andrzej Nowakowski","doi":"10.5603/gpl.101436","DOIUrl":"https://doi.org/10.5603/gpl.101436","url":null,"abstract":"<p><strong>Objectives: </strong>Free-of-charge vaccination against human papillomavirus (HPV-) of 12-13-year-old teenagers was introduced on the 1st of June 2023 in Poland. Data on baseline HPV- genotype cervical distribution are crucial to evaluate potential changes after full implementation of the vaccination program. We aimed at evaluating the status of HPV- infection and distribution of HPV- genotypes in cervical cytology of gynecological patients tested in one of the largest HPV- laboratories in Poland.</p><p><strong>Material and methods: </strong>Data on all HPV- tests performed in ALAB Laboratoria Sp. z o. o. in Poland in 2018-2021 were analyzed, focusing on tests that identified genotypes: 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 62, 66, 67, 68, 70, 73, 81, 82, 83, 89. Distribution of HPV- genotypes was assessed among HPV--positive women.</p><p><strong>Results: </strong>Among 11.151 medical records retrieved in women with valid HPV- test results, 5.681 were positive (50.9%), of whom 2.929 were infected with a single genotype (51.6%). At least one high-risk (HR) genotype was detected in 4.351 women (76.6%). Among all HPV--positive women, the most common HR genotypes were HPV--16, HPV--31 and HPV--66 (24.0%, 11.3%, 11.3%, respectively). HPV--53 was the most prevalent among non-HR types (10.5%).</p><p><strong>Conclusions: </strong>HPV--16 followed by HPV--31 and HPV--66 were the most frequent genotypes in the studied cohort. These results may be compared with the same methodology after full roll-out of HPV- vaccination program in the future to track potential changes in HPV- genotype distribution.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study reported the diagnosis, treatment and perinatal outcome of a novel coronavirus infection patient at 29+6 weeks pregnancy. The patient case came to the hospital with persistent fever and cough for 6 days. Patient's chest CT diagnosis showed double pneumonia, and viral infection was considered. Blood gas analysis revealed type I respiratory failure, and a throat swab nucleic acid test confirmed the novel coronavirus infection (critical type). After 13 days of isolation and supportive treatment, the patient recovered and was discharged from hospital after two consecutive negative nucleic acid tests. After discharge, the patient delivered a baby girl successfully by cesarean section on March 16, 2023. The newborn weighing 2050 g, with an Apgar score of 9-10 points /1-5 minutes. The newborn was transferred to the neonatology department for hospitalization and discharged 10 days later. The patient and her baby were followed up for nearly 1 year. Both mother and daughter were in good health.
{"title":"Severe novel coronavirus infection in late pregnancy: a case report.","authors":"Jingjing Liu, Bingzhe Wang, Na Yang, Zhengang Yu","doi":"10.5603/gpl.100177","DOIUrl":"https://doi.org/10.5603/gpl.100177","url":null,"abstract":"<p><p>This study reported the diagnosis, treatment and perinatal outcome of a novel coronavirus infection patient at 29+6 weeks pregnancy. The patient case came to the hospital with persistent fever and cough for 6 days. Patient's chest CT diagnosis showed double pneumonia, and viral infection was considered. Blood gas analysis revealed type I respiratory failure, and a throat swab nucleic acid test confirmed the novel coronavirus infection (critical type). After 13 days of isolation and supportive treatment, the patient recovered and was discharged from hospital after two consecutive negative nucleic acid tests. After discharge, the patient delivered a baby girl successfully by cesarean section on March 16, 2023. The newborn weighing 2050 g, with an Apgar score of 9-10 points /1-5 minutes. The newborn was transferred to the neonatology department for hospitalization and discharged 10 days later. The patient and her baby were followed up for nearly 1 year. Both mother and daughter were in good health.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marcin Januszewski, Laura M Ziuzia-Januszewska, Andrzej Durczynski, Jacek Holubka, Bogdan Siwek, Zofia Siwek, Zbigniew Derdziuk, Waldemar Wierzba, Artur J Jakimiuk
Objectives: The integration of high-risk human papillomavirus (HPV) detection into cervical cancer screening in Poland aims to improve early detection, yet challenges in coverage and adherence persist. Innovative approaches, like sampling for HPV testing and cytology outside medical settings, have been proposed. This study assesses the feasibility and agreement of results between traditional and novel sampling methods.
Material and methods: A cohort of 50 women aged 25-74 underwent HPV DNA and liquid-based cytology sampling both in-office using standard method and outside the medical setting by trained personnel. Samples were analyzed for HPV DNA using Real-Time PCR and cytology according to the Bethesda System.
Results: Cytology and HPV DNA positivity rates showed substantial agreement between methods, with almost perfect agreement for high-risk HPV types. Visual assessment of the cervix was successfully conducted in all cases. Preliminary results suggest remote sampling for HPV DNA and cytology is a viable alternative to traditional methods, with the effectiveness in detecting HPV and cytological abnormalities comparable to this reported in literature, offering potential benefits for individuals with mobility limitations or logistical barriers to attending medical appointments.
Conclusions: The study highlights the potential role of remote sampling for HPV DNA and cytology in enhancing cervical cancer screening accessibility and adherence. Implementation of such methods could improve coverage, particularly among underserved populations. Further research is needed to validate and optimize these approaches for broader clinical use.
目的:波兰将高危人乳头瘤病毒 (HPV) 检测纳入宫颈癌筛查旨在提高早期检测率,但在覆盖率和坚持率方面仍存在挑战。有人提出了一些创新方法,如在医疗机构外进行 HPV 检测和细胞学采样。本研究评估了传统采样方法和新型采样方法的可行性和结果一致性:50名年龄在25-74岁之间的女性接受了HPV DNA和液基细胞学采样。采用 Real-Time PCR 分析样本的 HPV DNA,并根据 Bethesda 系统进行细胞学分析:结果:细胞学和 HPV DNA 阳性率显示,不同方法的结果非常一致,高危 HPV 类型的结果几乎完全一致。所有病例都成功进行了宫颈肉眼评估。初步结果表明,HPV DNA 和细胞学远程取样是传统方法的一种可行替代方法,其检测 HPV 和细胞学异常的效果与文献报道的效果相当,为行动不便或有就诊后勤障碍的人提供了潜在的益处:这项研究强调了 HPV DNA 和细胞学远程采样在提高宫颈癌筛查的可及性和依从性方面的潜在作用。采用这种方法可以提高筛查覆盖率,特别是在服务不足的人群中。还需要进一步的研究来验证和优化这些方法,以便更广泛地应用于临床。
{"title":"Traditional vs novel out-of-office method for collecting cytology and HPV DNA - a comparative study.","authors":"Marcin Januszewski, Laura M Ziuzia-Januszewska, Andrzej Durczynski, Jacek Holubka, Bogdan Siwek, Zofia Siwek, Zbigniew Derdziuk, Waldemar Wierzba, Artur J Jakimiuk","doi":"10.5603/gpl.100294","DOIUrl":"https://doi.org/10.5603/gpl.100294","url":null,"abstract":"<p><strong>Objectives: </strong>The integration of high-risk human papillomavirus (HPV) detection into cervical cancer screening in Poland aims to improve early detection, yet challenges in coverage and adherence persist. Innovative approaches, like sampling for HPV testing and cytology outside medical settings, have been proposed. This study assesses the feasibility and agreement of results between traditional and novel sampling methods.</p><p><strong>Material and methods: </strong>A cohort of 50 women aged 25-74 underwent HPV DNA and liquid-based cytology sampling both in-office using standard method and outside the medical setting by trained personnel. Samples were analyzed for HPV DNA using Real-Time PCR and cytology according to the Bethesda System.</p><p><strong>Results: </strong>Cytology and HPV DNA positivity rates showed substantial agreement between methods, with almost perfect agreement for high-risk HPV types. Visual assessment of the cervix was successfully conducted in all cases. Preliminary results suggest remote sampling for HPV DNA and cytology is a viable alternative to traditional methods, with the effectiveness in detecting HPV and cytological abnormalities comparable to this reported in literature, offering potential benefits for individuals with mobility limitations or logistical barriers to attending medical appointments.</p><p><strong>Conclusions: </strong>The study highlights the potential role of remote sampling for HPV DNA and cytology in enhancing cervical cancer screening accessibility and adherence. Implementation of such methods could improve coverage, particularly among underserved populations. Further research is needed to validate and optimize these approaches for broader clinical use.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrzej Jaworowski, Agnieszka Micek, Magdalena Kolak, Katarzyna Skibinska, Julia Jurga, Kuba Ptaszkiewicz, Hubert Huras
Objectives: This study investigates the relationship between pre-pregnancy body mass index (BMI), BMI before labor, and weight gain during pregnancy with the incidence of cesarean delivery (CD) in dinoprostone-induced labor versus spontaneous labor.
Material and methods: This retrospective analysis was carried out at the Jagiellonian University Hospital's Obstetrics and Perinatology Department, encompassing term singleton pregnancies from May 2019 to February 2021. BMI was categorized following WHO guidelines. Gestational weight gain was assessed against the Institute of Medicine's 2009 recommendations.
Results: Of the 366 cases reviewed, 183 were in the dinoprostone-induced labor group, and 183 were in the spontaneous labor group. The study identified a significant association between higher pre-pregnancy BMI and increased weight gain during pregnancy with elevated CD rates, especially in dinoprostone-induced labor compared to spontaneous labor. Specifically, the dinoprostone-induced labor group showed a 33.9% CD rate compared to 16.9% in the spontaneous labor group. Logistic regression analysis further established that for each 1 kg/m² increase in pre-pregnancy BMI, the odds of undergoing a CD increased by 10%.
Conclusions: Elevated pre-pregnancy BMI and excessive gestational weight gain significantly heighten the risk of cesarean delivery, particularly in induced labor. The findings underline the need for individualized labor management strategies for women with higher BMI to optimize maternal and neonatal outcomes.
研究目的本研究调查了孕前体重指数(BMI)、分娩前体重指数和孕期体重增加与地诺前列酮引产和自然分娩的剖宫产(CD)发生率之间的关系:这项回顾性分析是在雅盖隆大学医院产科和围产医学科进行的,涵盖了2019年5月至2021年2月期间的足月单胎妊娠。体重指数按照世界卫生组织指南进行分类。妊娠体重增加根据医学研究所 2009 年的建议进行评估:在所审查的 366 例病例中,183 例属于地诺前列酮诱导分娩组,183 例属于自然分娩组。研究发现,孕前体重指数(BMI)较高和孕期体重增加与 CD 发生率升高之间存在显著关联,尤其是二烯丙基锂诱导分娩与自然分娩相比。具体来说,地诺前列酮引产组的 CD 发生率为 33.9%,而自然分娩组为 16.9%。逻辑回归分析进一步证实,孕前体重指数每增加 1 kg/m²,发生难产的几率就会增加 10%:结论:孕前体重指数(BMI)升高和妊娠期体重增加过多会显著增加剖宫产的风险,尤其是在引产过程中。研究结果表明,有必要为体重指数较高的产妇制定个性化的分娩管理策略,以优化孕产妇和新生儿的预后。
{"title":"Impact of body mass index and gestational weight gain on cesarean delivery rates: a comparative study of dinoprostone-induced vs spontaneous labor.","authors":"Andrzej Jaworowski, Agnieszka Micek, Magdalena Kolak, Katarzyna Skibinska, Julia Jurga, Kuba Ptaszkiewicz, Hubert Huras","doi":"10.5603/gpl.100230","DOIUrl":"https://doi.org/10.5603/gpl.100230","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigates the relationship between pre-pregnancy body mass index (BMI), BMI before labor, and weight gain during pregnancy with the incidence of cesarean delivery (CD) in dinoprostone-induced labor versus spontaneous labor.</p><p><strong>Material and methods: </strong>This retrospective analysis was carried out at the Jagiellonian University Hospital's Obstetrics and Perinatology Department, encompassing term singleton pregnancies from May 2019 to February 2021. BMI was categorized following WHO guidelines. Gestational weight gain was assessed against the Institute of Medicine's 2009 recommendations.</p><p><strong>Results: </strong>Of the 366 cases reviewed, 183 were in the dinoprostone-induced labor group, and 183 were in the spontaneous labor group. The study identified a significant association between higher pre-pregnancy BMI and increased weight gain during pregnancy with elevated CD rates, especially in dinoprostone-induced labor compared to spontaneous labor. Specifically, the dinoprostone-induced labor group showed a 33.9% CD rate compared to 16.9% in the spontaneous labor group. Logistic regression analysis further established that for each 1 kg/m² increase in pre-pregnancy BMI, the odds of undergoing a CD increased by 10%.</p><p><strong>Conclusions: </strong>Elevated pre-pregnancy BMI and excessive gestational weight gain significantly heighten the risk of cesarean delivery, particularly in induced labor. The findings underline the need for individualized labor management strategies for women with higher BMI to optimize maternal and neonatal outcomes.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Malgorzata Wiech, Ewa Kawiak-Jawor, Marta Baranska, Julia Zareba-Szczudlik, Halina Weker
Objectives: During the life cycle of a woman, pregnancy is the period when she is most open to changing her behaviour and lifestyle for the benefit of the child's development. Lifestyle changes include also the diet correction. The objective of the study was to assess, through identified dietary patterns, the diets of women in the second and third trimester of pregnancy in relation to their nutritional status before and during pregnancy.
Material and methods: The study was conducted among pregnant women, participants of childbirth education classes at the Institute of Mother and Child, based on food frequency questionnaire. The study involved 392 women in the age 19-40 years (first single pregnancy without complications). Dietary patterns were identified using the k-means method, based on groups of products.
Results: Three dietary patters were identified in the study group of women: dietary pattern 1 - cereal-milk diet, dietary pattern 2 - vegetable-fruit diet and dietary pattern 3 - cottage cheese-vegetable diet. Dietary pattern 3 occurred in 43.9% of underweight women, in 45.5% of women with normal weight and in 43.1% of women with excess body weight. Dietary pattern 1 occurred in about one third of women and dietary pattern 2 in about 20% in each group. A greater diversity in the frequency of identified dietary patterns was observed in relation to weight gain during pregnancy. The identified dietary patterns differed significantly in terms of the profile of macronutrients, most minerals and vitamins - E, C and B group vitamins.
Conclusions: The identified dietary patterns and their energy and nutritional profile indicate the need for monitoring the diets and nutritional education of pregnant women.
{"title":"Dietary patterns of Polish pregnant women in reference to prepregnancy BMI and gestational weight gain.","authors":"Malgorzata Wiech, Ewa Kawiak-Jawor, Marta Baranska, Julia Zareba-Szczudlik, Halina Weker","doi":"10.5603/gpl.98382","DOIUrl":"https://doi.org/10.5603/gpl.98382","url":null,"abstract":"<p><strong>Objectives: </strong>During the life cycle of a woman, pregnancy is the period when she is most open to changing her behaviour and lifestyle for the benefit of the child's development. Lifestyle changes include also the diet correction. The objective of the study was to assess, through identified dietary patterns, the diets of women in the second and third trimester of pregnancy in relation to their nutritional status before and during pregnancy.</p><p><strong>Material and methods: </strong>The study was conducted among pregnant women, participants of childbirth education classes at the Institute of Mother and Child, based on food frequency questionnaire. The study involved 392 women in the age 19-40 years (first single pregnancy without complications). Dietary patterns were identified using the k-means method, based on groups of products.</p><p><strong>Results: </strong>Three dietary patters were identified in the study group of women: dietary pattern 1 - cereal-milk diet, dietary pattern 2 - vegetable-fruit diet and dietary pattern 3 - cottage cheese-vegetable diet. Dietary pattern 3 occurred in 43.9% of underweight women, in 45.5% of women with normal weight and in 43.1% of women with excess body weight. Dietary pattern 1 occurred in about one third of women and dietary pattern 2 in about 20% in each group. A greater diversity in the frequency of identified dietary patterns was observed in relation to weight gain during pregnancy. The identified dietary patterns differed significantly in terms of the profile of macronutrients, most minerals and vitamins - E, C and B group vitamins.</p><p><strong>Conclusions: </strong>The identified dietary patterns and their energy and nutritional profile indicate the need for monitoring the diets and nutritional education of pregnant women.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katarzyna Zych-Krekora, Oskar Sylwestrzak, Michal Krekora, Przemyslaw Oszukowski, Katarzyna Wachowska, Piotr Galecki, Mariusz Grzesiak
Objectives: Pregnancy is a special time that brings both joy and challenges. Among these challenges, anxiety and stress are emotions that can affect the mental wellbeing of the pregnant woman as well as the developing baby.
Material and methods: In response to these challenges, we present the Pregnancy Anxiety and Stress Rating Scale (PASRS), an innovative tool that aims to identify and assess anxiety and stress levels among pregnant women.
Results: The PASRS contains 15 questions that are more comprehensive and cover various aspects of pregnancy, including the health of the baby, the health of the mother, body changes, finances and social support.
Conclusions: In an era where mental health is just as important as physical health, SOLiSC is a step forward in recognising and addressing the unique mental challenges that pregnant women may face.
{"title":"Assessment of emotions in pregnancy: introduction of the Pregnancy Anxiety and Stress Rating Scale (PASRS) and its application in the context of hospitalization.","authors":"Katarzyna Zych-Krekora, Oskar Sylwestrzak, Michal Krekora, Przemyslaw Oszukowski, Katarzyna Wachowska, Piotr Galecki, Mariusz Grzesiak","doi":"10.5603/gpl.100450","DOIUrl":"https://doi.org/10.5603/gpl.100450","url":null,"abstract":"<p><strong>Objectives: </strong>Pregnancy is a special time that brings both joy and challenges. Among these challenges, anxiety and stress are emotions that can affect the mental wellbeing of the pregnant woman as well as the developing baby.</p><p><strong>Material and methods: </strong>In response to these challenges, we present the Pregnancy Anxiety and Stress Rating Scale (PASRS), an innovative tool that aims to identify and assess anxiety and stress levels among pregnant women.</p><p><strong>Results: </strong>The PASRS contains 15 questions that are more comprehensive and cover various aspects of pregnancy, including the health of the baby, the health of the mother, body changes, finances and social support.</p><p><strong>Conclusions: </strong>In an era where mental health is just as important as physical health, SOLiSC is a step forward in recognising and addressing the unique mental challenges that pregnant women may face.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142304675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jeannine M Miranne, Iwona Gabriel, Maura Kelly, Alexa Courtepatte, Vatche A Minassian
Objectives: To estimate the prevalence of UI and POP after hysterectomy for benign disease and gynecologic malignancy. This is a retrospective cohort chart review study. Two major urban tertiary care centers between 2006-2010. Women ≥ 18 years undergoing hysterectomy for benign or malignant indications.
Material and methods: Presence of UI and POP was based on patient report in clinic notes, ICD-9 UI and POP diagnosis codes, and CPT codes for treatment. Prevalence of UI and POP after hysterectomy and time to development of UI and POP after hysterectomy.
Results: 1363 (55%) women underwent hysterectomy for benign disease while 1107 (45%) had a hysterectomy for malignancy. Postoperative prevalence of UI and POP in the benign versus the malignant group was 15.1% vs 11.1% (p = 0.001), and 12.1% vs 2.8%, (p < 0.001), respectively. The median time to development of UI in the subset of patients without preoperative UI was 3.5 years in the benign group vs 3 years in the malignant group (p < 0.001). The median time to development of POP in the subset of patients without preoperative POP was 5 years in the benign group and 3.5 years in the malignant group (p < 0.001). There was no significant difference in the risk of developing UI or POP between groups after adjusting for confounders or when accounting for pre-hysterectomy UI or POP.
Conclusions: When pre-hysterectomy UI or POP is taken into consideration, there is no difference in the prevalence of post-hysterectomy UI or POP.
目的估计良性疾病和妇科恶性肿瘤子宫切除术后 UI 和 POP 的发病率。这是一项回顾性队列病历审查研究。研究对象为 2006-2010 年间两个主要的城市三级医疗中心。因良性或恶性指征接受子宫切除术的≥18岁女性:根据患者在门诊笔记中的报告、ICD-9 UI 和 POP 诊断代码以及 CPT 治疗代码确定是否存在 UI 和 POP。子宫切除术后 UI 和 POP 的发病率以及子宫切除术后 UI 和 POP 的发病时间:1363名(55%)妇女因良性疾病接受了子宫切除术,1107名(45%)妇女因恶性肿瘤接受了子宫切除术。良性组与恶性组的术后尿失禁和子宫内膜异位症发病率分别为 15.1% 对 11.1% (P = 0.001)和 12.1% 对 2.8% (P < 0.001)。在没有术前UI的患者子集中,良性组发生UI的中位时间为3.5年,而恶性组为3年(P < 0.001)。在没有术前POP的患者子集中,良性组发生POP的中位时间为5年,恶性组为3.5年(P < 0.001)。在对混杂因素进行调整后,或考虑到子宫切除术前UI或POP时,各组间发生UI或POP的风险无明显差异:结论:如果考虑到子宫切除术前的 UI 或 POP,子宫切除术后 UI 或 POP 的发病率没有差异。
{"title":"Prevalence of urinary incontinence and prolapse after hysterectomy for benign disease versus gynecologic malignancy.","authors":"Jeannine M Miranne, Iwona Gabriel, Maura Kelly, Alexa Courtepatte, Vatche A Minassian","doi":"10.5603/gpl.98184","DOIUrl":"https://doi.org/10.5603/gpl.98184","url":null,"abstract":"<p><strong>Objectives: </strong>To estimate the prevalence of UI and POP after hysterectomy for benign disease and gynecologic malignancy. This is a retrospective cohort chart review study. Two major urban tertiary care centers between 2006-2010. Women ≥ 18 years undergoing hysterectomy for benign or malignant indications.</p><p><strong>Material and methods: </strong>Presence of UI and POP was based on patient report in clinic notes, ICD-9 UI and POP diagnosis codes, and CPT codes for treatment. Prevalence of UI and POP after hysterectomy and time to development of UI and POP after hysterectomy.</p><p><strong>Results: </strong>1363 (55%) women underwent hysterectomy for benign disease while 1107 (45%) had a hysterectomy for malignancy. Postoperative prevalence of UI and POP in the benign versus the malignant group was 15.1% vs 11.1% (p = 0.001), and 12.1% vs 2.8%, (p < 0.001), respectively. The median time to development of UI in the subset of patients without preoperative UI was 3.5 years in the benign group vs 3 years in the malignant group (p < 0.001). The median time to development of POP in the subset of patients without preoperative POP was 5 years in the benign group and 3.5 years in the malignant group (p < 0.001). There was no significant difference in the risk of developing UI or POP between groups after adjusting for confounders or when accounting for pre-hysterectomy UI or POP.</p><p><strong>Conclusions: </strong>When pre-hysterectomy UI or POP is taken into consideration, there is no difference in the prevalence of post-hysterectomy UI or POP.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: This study aims to elucidate the expression patterns of LGALS1 (galectin-1) and LGALS9 (galectin-9) genes in placental tissues of pregnancies affected by preterm prelabor rupture of membranes (PPROM). The overarching goal is to understand the potential roles of these galectins in the pathophysiology of PPROM, particularly in maternal-fetal immune tolerance and placental development.
Material and methods: Conducted as a prospective, single-center study at the Gynecology and Obstetrics Clinical Hospital in Poznan, Poland, from June 2021 to May 2023, the research involved 25 participants, including 12 with PPROM and 13 healthy controls. Placental tissues were obtained, and RNA extraction was performed. Galectin gene expression (LGALS1 and LGALS9) was analyzed using quantitative real-time PCR. Demographic and clinical data were collected, and statistical analyses were employed to assess correlations between galectin expression and clinical parameters.
Results: While significant differences were observed in gestational age at delivery and birth weight between the PPROM and control groups, the expression levels of LGALS1 and LGALS9 did not show statistically significant variations. Correlation analyses revealed no significant associations between galectin expression and various clinical parameters.
Conclusions: Contrary to the hypothesis, this study did not identify significant alterations in galectin-1 and galectin-9 expression in placentas affected by PPROM. Despite the limitations of a small sample size, these findings provide initial insights into the potential roles of galectins in PPROM. Further research on larger cohorts is warranted to comprehensively understand the implications of galectin involvement in the pathophysiology of PPROM.
{"title":"","authors":"Dorota G Boron, Joanna Mikolajczyk-Stecyna, Agata Chmurzynska, Grazyna Kurzawinska, Wieslaw Markwitz, Agnieszka Seremak-Mrozikiewicz","doi":"10.5603/gpl.98834","DOIUrl":"https://doi.org/10.5603/gpl.98834","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to elucidate the expression patterns of LGALS1 (galectin-1) and LGALS9 (galectin-9) genes in placental tissues of pregnancies affected by preterm prelabor rupture of membranes (PPROM). The overarching goal is to understand the potential roles of these galectins in the pathophysiology of PPROM, particularly in maternal-fetal immune tolerance and placental development.</p><p><strong>Material and methods: </strong>Conducted as a prospective, single-center study at the Gynecology and Obstetrics Clinical Hospital in Poznan, Poland, from June 2021 to May 2023, the research involved 25 participants, including 12 with PPROM and 13 healthy controls. Placental tissues were obtained, and RNA extraction was performed. Galectin gene expression (LGALS1 and LGALS9) was analyzed using quantitative real-time PCR. Demographic and clinical data were collected, and statistical analyses were employed to assess correlations between galectin expression and clinical parameters.</p><p><strong>Results: </strong>While significant differences were observed in gestational age at delivery and birth weight between the PPROM and control groups, the expression levels of LGALS1 and LGALS9 did not show statistically significant variations. Correlation analyses revealed no significant associations between galectin expression and various clinical parameters.</p><p><strong>Conclusions: </strong>Contrary to the hypothesis, this study did not identify significant alterations in galectin-1 and galectin-9 expression in placentas affected by PPROM. Despite the limitations of a small sample size, these findings provide initial insights into the potential roles of galectins in PPROM. Further research on larger cohorts is warranted to comprehensively understand the implications of galectin involvement in the pathophysiology of PPROM.</p>","PeriodicalId":94021,"journal":{"name":"Ginekologia polska","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}